Pharmaceuticals

Prostate Cancer Therapeutics Market was valued at US$ 14,767.73 Million in 2022 and is expected to reach to US$ 28,425.27 Million by 2030; it is estimated to record a CAGR of 8.5% from 2022 to 2030

• Pharmaceuticals

Prostate Cancer Therapeutics Market was valued at US$ 14,767.73 Million in 2022 and is expected to reach to US$ 28,425.27 Million by 2030; it is estimated to record a CAGR of 8.5% from 2022 to 2030

Market News Insights October 24, 2024

The increasing number of prostate cancer cases and rising strategic initiatives by the prostate cancer therapeutics market...

Read More Read more about Prostate Cancer Therapeutics Market was valued at US$ 14,767.73 Million in 2022 and is expected to reach to US$ 28,425.27 Million by 2030; it is estimated to record a CAGR of 8.5% from 2022 to 2030

Sarcopenia Treatment Market was valued at US$ 3,397.62 Million in 2022 and is expected to reach to US$ 5,264.76 Million by 2030; it is estimated to record a CAGR of 5.6% from 2022 to 2030

• Pharmaceuticals

Sarcopenia Treatment Market was valued at US$ 3,397.62 Million in 2022 and is expected to reach to US$ 5,264.76 Million by 2030; it is estimated to record a CAGR of 5.6% from 2022 to 2030

Market News Insights October 18, 2024

Rising Awareness of Sarcopenia to Bring New Growth Trends into Sarcopenia Treatment Market The growing awareness of...

Read More Read more about Sarcopenia Treatment Market was valued at US$ 3,397.62 Million in 2022 and is expected to reach to US$ 5,264.76 Million by 2030; it is estimated to record a CAGR of 5.6% from 2022 to 2030

Malaria Diagnostics Market was valued at US$ 782.57 Million in 2022 and is expected to reach to US$ 1,200.24 Million by 2030; it is estimated to record a CAGR of 5.5% from 2022 to 2030

• Pharmaceuticals

Malaria Diagnostics Market was valued at US$ 782.57 Million in 2022 and is expected to reach to US$ 1,200.24 Million by 2030; it is estimated to record a CAGR of 5.5% from 2022 to 2030

Market News Insights October 18, 2024

Rising Initiatives to Raise Awareness about Malaria Drives Malaria Diagnostics Market According to the latest World Malaria...

Read More Read more about Malaria Diagnostics Market was valued at US$ 782.57 Million in 2022 and is expected to reach to US$ 1,200.24 Million by 2030; it is estimated to record a CAGR of 5.5% from 2022 to 2030

Parenteral Nutrition Market was valued at US$ 6.84 Billion in 2022 and is expected to reach to US$ 11.12 Billion by 2030; it is estimated to record a CAGR of 6.2% from 2022 to 2030

• Pharmaceuticals

Parenteral Nutrition Market was valued at US$ 6.84 Billion in 2022 and is expected to reach to US$ 11.12 Billion by 2030; it is estimated to record a CAGR of 6.2% from 2022 to 2030

Market News Insights October 16, 2024

Surge in Cases of Malnutrition and Premature Births Drives Parenteral Nutrition Market Malnutrition includes being undernourished, overweight...

Read More Read more about Parenteral Nutrition Market was valued at US$ 6.84 Billion in 2022 and is expected to reach to US$ 11.12 Billion by 2030; it is estimated to record a CAGR of 6.2% from 2022 to 2030

Oncology Biosimilars Market was valued at US$ 9.46 Billion in 2023 and is expected to reach to US$ 24.71 Billion by 2031; it is estimated to record a CAGR of 12.8% from 2023 to 2031

• Pharmaceuticals

Oncology Biosimilars Market was valued at US$ 9.46 Billion in 2023 and is expected to reach to US$ 24.71 Billion by 2031; it is estimated to record a CAGR of 12.8% from 2023 to 2031

Market News Insights October 16, 2024

North America accounts for a major oncology biosimilars market share in 2023, followed by Europe. The growing...

Read More Read more about Oncology Biosimilars Market was valued at US$ 9.46 Billion in 2023 and is expected to reach to US$ 24.71 Billion by 2031; it is estimated to record a CAGR of 12.8% from 2023 to 2031

Glaucoma therapeutics Market was valued at US$ 6.24 Billion in 2023 and is expected to reach to US$ 8.02 Billion by 2031; it is estimated to record a CAGR of 3.2% from 2023 to 2031

• Pharmaceuticals

Glaucoma therapeutics Market was valued at US$ 6.24 Billion in 2023 and is expected to reach to US$ 8.02 Billion by 2031; it is estimated to record a CAGR of 3.2% from 2023 to 2031

Market News Insights October 15, 2024

Glaucoma is a group of eye disorders caused due to the damage incurred to the optic nerve,...

Read More Read more about Glaucoma therapeutics Market was valued at US$ 6.24 Billion in 2023 and is expected to reach to US$ 8.02 Billion by 2031; it is estimated to record a CAGR of 3.2% from 2023 to 2031

Plasma Therapy Market was valued at US$ 390.25 Million in 2022 and is expected to reach to US$ 1,097.64 Million by 2030; it is estimated to record a CAGR of 13.80% from 2022 to 2030

• Pharmaceuticals

Plasma Therapy Market was valued at US$ 390.25 Million in 2022 and is expected to reach to US$ 1,097.64 Million by 2030; it is estimated to record a CAGR of 13.80% from 2022 to 2030

Market News Insights October 15, 2024

North America dominated the plasma therapy market in 2022. It is further expected to record the highest...

Read More Read more about Plasma Therapy Market was valued at US$ 390.25 Million in 2022 and is expected to reach to US$ 1,097.64 Million by 2030; it is estimated to record a CAGR of 13.80% from 2022 to 2030

Hyperpigmentation Disorder Treatment Market was valued at US$ 6.67 Billion in 2022 and is expected to reach to US$ 11.78 Billion by 2030; it is estimated to record a CAGR of 7.4% from 2022 to 2030

• Pharmaceuticals

Hyperpigmentation Disorder Treatment Market was valued at US$ 6.67 Billion in 2022 and is expected to reach to US$ 11.78 Billion by 2030; it is estimated to record a CAGR of 7.4% from 2022 to 2030

Market News Insights October 11, 2024

Geographically, the global hyperpigmentation disorder treatment market is segmented into North America, Asia Pacific, Europe, the Middle...

Read More Read more about Hyperpigmentation Disorder Treatment Market was valued at US$ 6.67 Billion in 2022 and is expected to reach to US$ 11.78 Billion by 2030; it is estimated to record a CAGR of 7.4% from 2022 to 2030

Hospital Acquired Infection Treatment Market was valued at US$ 15,099.19 Million in 2022 and is expected to reach to US$ 19,978.39 Million by 2030; it is estimated to record a CAGR of 3.6% from 2022 to 2030

• Pharmaceuticals

Hospital Acquired Infection Treatment Market was valued at US$ 15,099.19 Million in 2022 and is expected to reach to US$ 19,978.39 Million by 2030; it is estimated to record a CAGR of 3.6% from 2022 to 2030

Market News Insights October 10, 2024

Asia Pacific is the fastest-growing market for hospital acquired infection treatment. North America accounted for the largest...

Read More Read more about Hospital Acquired Infection Treatment Market was valued at US$ 15,099.19 Million in 2022 and is expected to reach to US$ 19,978.39 Million by 2030; it is estimated to record a CAGR of 3.6% from 2022 to 2030

Fluorine-18 Market was valued at US$ 1.72 Billion in 2022 and is expected to reach to US$ 2.41 Billion by 2030; it is estimated to record a CAGR of 4.3% from 2022 to 2030

• Pharmaceuticals

Fluorine-18 Market was valued at US$ 1.72 Billion in 2022 and is expected to reach to US$ 2.41 Billion by 2030; it is estimated to record a CAGR of 4.3% from 2022 to 2030

Market News Insights October 8, 2024

Factors such as the heightened prevalence of chronic diseases and increasing use of nuclear imaging techniques propel...

Read More Read more about Fluorine-18 Market was valued at US$ 1.72 Billion in 2022 and is expected to reach to US$ 2.41 Billion by 2030; it is estimated to record a CAGR of 4.3% from 2022 to 2030